ICAM-1 and VCAM-1 have been proposed as early biomarkers of changes in the artery wall [23] and to play a major role in the development of atherosclerosis; therefore, both are considered preclinical markers of endothelial dysfunction. Here, VCAM1 is linked to endothelial dysfunction.